Exane Asset Management’s Adverum Biotechnologies ADVM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,800	Closed	-$411K	–	110
2018 Q3	$411K	Buy	6,800 +1,800	+36%	+$109K	0.13%	54
2018 Q2	$265K	Buy	+5,000	New	+$265K	0.11%	52